Mechanisms of N6‑methyladenosine modification in tumor development and potential therapeutic strategies (Review)
International Journal of Oncology · 18.05.2023 · 62 (6)
DOI: 10.3892/ijo.2023.5523 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 18.05.2023. Verfasst von Xi Pu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Jiangsu University Cancer Institute, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China. Hauptthemen laut MEDLINE: Neoplasms, Ferroptosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
N6‑methyladenosine (m6A) modification, as the most common and abundant type of RNA modification in mammalian cells, participates in the processes of mRNA transcription, translation, splicing and degradation, serving to regulate RNA stability. In recent years, a large number of studies have indicated that m6A modification is able to affect tumor progression, participate in tumor metabolism, regulate tumor cell ferroptosis and change the tumor immune microenvironment, thereby affecting tumor immunotherapy. In the current review, the main features of m6A‑associated proteins are presented with a focus on the mechanisms underpinning their roles in tumor progression, metabolism, ferroptosis and immunotherapy, also emphasizing the potential of targeting m6A‑associated proteins as a promising strategy for the treatment of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Jiangsu University Cancer Institute, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China.
- Department of Radiation Oncology, Jiangsu University Cancer Institute, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China.
- Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang Jiangsu 212013, P.R. China.
Zitieren
APA
Pu, X., Wu, Y., Ji, Q., Fu, S., Zuo, H., Chu, L., Tang, H., Wan, M., Wang, X., & Xu, M. (2023). Mechanisms of N6‑methyladenosine modification in tumor development and potential therapeutic strategies (Review). International Journal of Oncology, 62(6). https://doi.org/10.3892/ijo.2023.5523
Vancouver
Pu X, Wu Y, Ji Q, Fu S, Zuo H, Chu L, et al. Mechanisms of N6‑methyladenosine modification in tumor development and potential therapeutic strategies (Review). International Journal of Oncology. 2023;62(6). doi:10.3892/ijo.2023.5523
BibTeX
@article{Pu2023,
author = {Pu, Xi and Wu, Yuting and Ji, Qian and Fu, Shengqiao and Zuo, Hao and Chu, Liangmei and Tang, Haowen and Wan, Mengtian and Wang, Xu and Xu, Min},
title = {Mechanisms of N6‑methyladenosine modification in tumor development and potential therapeutic strategies (Review)},
journal = {International Journal of Oncology},
year = {2023},
volume = {62},
number = {6},
doi = {10.3892/ijo.2023.5523}
}
EUVIMED